Upcoming Conferences

Partnering for Cures
November 6-8, 2011 I New York City

The ADDF’s Executive Director, Dr. Howard Fillit, participated in the  “Philanthropy As Risk Capital” panel at FasterCures’ Partnering for Cures meeting. The panel addressed how efforts by the “venture philanthropy” community are breaking down the barriers to medical progress and de-risking investment by other sectors.

Watch the panel discussion here.

6th Drug Discovery for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs
February 12-14, 2012 | New York City

The Drug Discovery for Neurodegeneration course advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies. The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges.  The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.

Conference Website

Targeting Vasculature in Alzheimer’s Disease and Vascular Cognitive Impairment
May 4, 2012 | New York City

Vascular pathology has been long established, but under appreciated, as a contributing factor in Alzheimer’s disease (AD). It is likely that vascular alterations are both a cause and a consequence of neuronal loss. This conference will present the current clinical knowledge of the vascular connection to AD pathogenesis and will highlight novel vascular approaches to intervention that can be applied to Alzheimer’s disease therapeutic development.

Conference Website

13th International Conference on Alzheimer’s Drug Discovery
September 10-11, 2012Jersey City, New Jersey

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientist in the field will present their current research, provide progress updates and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.  The conference website and registration information will be available soon.

For more information about an upcoming conference, please contact Filomena Machleder at 212-901-8004 or fmachleder@alzdiscovery.org.

1 out of 3 individuals will be affected by Alzheimer's Disease by the age of 80.

Donate Now

We're doing whatever it takes to find a cure for Alzheimer's Disease. But we can't do it without you. Please give generously today. Learn More

Apply for a Grant

ADDF invites scientists to apply for a grant through its Novel Approaches to Drug Discovery for Alzheimer's Disease research award program. Learn More